Asst Prof Valerie Yang Shiwen

Asst Professor Valerie Yang is a Visiting Consultant, Division of Medical Oncology at the National Cancer Centre Singapore. She is jointly appointed as a Research Clinician & Group Leader at the Institute of Molecular and Cell Biology, A*STAR. Her interests include Sarcomas, Lymphomas and Melanomas.

She received the National Science Scholarship from the Agency for Science, Technology and Research (A*STAR) to read Medicine and a PhD. She graduated from the Royal Free and University College Medical School with Distinctions in Preclinical Medicine and First Class Honours for a Bach-elor of Science (BSc) in Molecular Medicine. She was conferred the Cluff Memorial Prize and the Goldberg-Schachmann and Freda Becker Memorial Award, and joined the A*STAR Chairman’s Honours List. Dr. Yang then read Clinical Medicine at the University of Cambridge, where she was accepted into the prestigious MB/PhD Programme. Her PhD in Oncology was supervised by Dr. Michael Gonzalez and Professor Ronald Laskey, where she studied DNA replication, cell cycle regulation and embryonic stem cell pluripotency.

Upon returning to Singapore, Dr. Yang underwent Internal Medicine residency training and was accepted to the Membership of the Royal College of Physicians (MRCP), UK, before receiving specialty training in Medical Oncology at the NCCS. She was also conferred the Nurturing Clinician Scientists Scheme Award (NCSS) by SingHealth for Sarcoma research while concurrently undergoing specialty training. She is now accredited as a Specialist in Medical Oncology and a Fellow of the Academy of Medicine of Singapore. As an Associate Consultant, she also won the National Medical Research Council (NMRC) Transition Award 2021 for her work in Sarcomas.

• Fellow, College of Clinician Scientists, Academy of Medicine, Singapore, 2021
• Fellow of the Academy of Medicine, Singapore (Medical Oncology), 2019
• Specialist Accreditation in Medical Oncology, Ministry of Health Singapore, 2019
• MRCP, Royal College of Physicians (UK), 2014
• PhD, University of Cambridge, 2010
• MBBChir, University of Cambridge, 2010
• Bachelor of Science with First Class Honours, University College London, 2003

• Mentor, SingHealth Internal Medicine Residency Program, 2021 – Present
• Internal Medicine Panel, Department of Internal Medicine, Singapore General Hospital, 2021 - Present 
  
• Consultant, Division of Medical Oncology, National Cancer Centre Singapore, 2021 - Present
• Assistant Professor, Oncology Academic Clinical Program, Duke-NUS Medical School, 2021 - Present
• Clinical Physician Faculty Member, SingHealth Medical Oncology Residency Programme, 2021 – Present
• Associate Consultant, Division of Medical Oncology, National Cancer Centre Singapore, 2019 – 2021
• Research Clinician & Group Leader, Institute of Molecular and Cell Biology, A*STAR, 2019 - Present
• Adjunct Instructor, Oncology Academic Clinical Program, Duke-NUS Medical School, 2019 – 2021
• American Association for Cancer Research, 2015 - Present
• Singapore Society of Oncology (SSO), 2014 – Present
• American Society of Clinical Oncology (ASCO), 2014 – Present
• European Society of Medical Oncology (ESMO), 2014 – Present

• Singhealth Long Service Award, 2022
• National Medical Research Council (NMRC) Transition Award, 2021
• Nurturing Clinician Scientists Scheme Award, SingHealth, 2016
• Academic Development Programme, National University Hospital, 2012
• First Prize for Oral Presentation, Graduate Research Symposium, Cambridge University, 2009
• Goldberg-Schachmann and Freda Becker Memorial award, University of London, 2003
• Cluff Memorial Prize, Royal Free and University College Medical School, 2003
• Distinction in Medical Sciences, Royal Free and University College Medical School, 2003
• Chairman’s Honours List, A*STAR Graduate Academy, 2003

• National Science Scholarship (MBBS-PhD), A*STAR, 2001

• Drug screening
• Biomarkers
• Patient-derived models
• Immunotherapy
• Translational Artificial Intelligence and Machine Learning
• Single-cell and digital spatial profiling technologies
• Personalised medicine
• Cancer epigenetics
• Sarcoma, Lymphoma, Melanoma, Skin and rare cancers